What are the odds of dying from Alzheimer's disease or other dementia?
Evidence quality 4.75/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 5/5
- D5 Scope
- 5/5
- D6 Prose
- 4/5
- D7 Perception honesty
- 5/5
- D8 Caveat completeness
- 4/5
● your factors — click this risk ▾ to reveal
- Your factors
≈ As likely as
Perceived
Dementia gets steady cultural airtime — prestige movies, celebrity diagnoses, think pieces about ageing parents — and yet it rarely shows up near the top of fear surveys ordered by the raw probability the fear represents. Most adults file Alzheimer’s as "a tragedy that happens to some elderly people" rather than as "the thing that has a roughly 1-in-5 chance of ending my own life if I make it to 80". The perceived-vs-actual gap is not that the fear is invisible; it is that the personal odds attached to it are wildly underappreciated. When the Alzheimer’s Association asks directly, people do rank it high — but ask the same people to guess their own lifetime risk from age 65 and the median answer is nowhere near the real ~1 in 4 to 1 in 5.
Rough estimate: ~48% of adults 50-64 are concerned about developing dementia; 73% of those with a family history consider themselves likely to develop it
Actual
~57 million people living with dementia worldwide; ~10 million new cases per year
global adults
Show derivation
Uses the WHO 2025 dementia fact sheet headline of 57 million people living with dementia worldwide in 2021 and nearly 10 million new cases per year as the global incidence anchor. Two complementary routes to a lifetime figure: (a) Direct from the Alzheimer’s Association 2025 Facts and Figures, which puts the conditional lifetime risk for Alzheimer’s specifically, from age 45, at 1 in 5 for women and 1 in 10 for men in the US — i.e. roughly a 15% population average lifetime incidence from mid-life, before adding non-Alzheimer’s dementias that push the all-cause dementia lifetime incidence closer to 25%. (b) From global mortality: WHO ranks dementia as the 7th leading cause of death globally; the Alzheimer’s Association reports Alzheimer’s as the 6th leading cause of death among US adults 65+; CDC FastStats reports ~116,000 US Alzheimer’s deaths in the most recent year of vital-registration data. Dementia is underreported on death certificates (the immediate cause of death is usually coded as pneumonia, cardiac arrest, or "failure to thrive"), so both WHO and GBD treat the reported count as a floor. Adjusting for underreporting, roughly 12-15% of adults alive today worldwide are likely to die of dementia or with dementia as a primary contributing cause if they survive other causes long enough. Headline figure 0.12 (≈ 1 in 8) with an uncertainty band of 0.09 to 0.18 to reflect the gap between the narrow death-certificate count and the broader "dying with dementia" framing, and to capture the large spread between regions where most adults die before the peak dementia-risk decades (sub-Saharan Africa, South Asia) and regions where most adults now routinely reach 85+ (high-income Asia-Pacific, Western Europe). Scope is global-adult-lifetime because the US-only number is meaningfully higher (~20-25% lifetime incidence from 65+) and would overstate the global baseline.
Caveats: Two methodological issues shape every dementia mortality number: underreporting …
Two methodological issues shape every dementia mortality number: underreporting on death certificates (the proximal cause recorded is usually something else, which is why CDC’s ~116,000 US Alzheimer’s-coded deaths sits roughly one order of magnitude below the Alzheimer’s Association’s "one in three older Americans dies with Alzheimer’s or another dementia" framing) and the distinction between Alzheimer’s disease specifically (~60-70% of dementias) and all-cause dementia. This entry is all-cause dementia mortality; the headline figure sits between the narrow coded-Alzheimer’s floor and the broader "dying with dementia" ceiling. The regional_breakdown entries for women vs men are population averages and do not control for competing mortality cleanly; the gap shrinks but does not close in cohorts restricted to adults who survive to age 80. Personal factor multipliers are illustrative relative risks from the epidemiological literature and overlap with one another (APOE status, family history, and composite lifestyle factors are not independent). Finally, the Lancet Commission’s 45% preventable-fraction is a population-attributable estimate under an idealised counterfactual where every modifiable factor is eliminated from birth; real-world individual effect sizes are closer to a 30-50% relative risk reduction for a composite healthy-brain profile.
How the risk varies
The headline figure averages across very different situations. Here’s how the probability varies by scenario or context:
1 in 8.3 · 12%
All-cause dementia lifetime mortality; WHO 7th-leading-cause-of-death anchor
1 in 4.0 · 25%
Those who reach 65 face roughly a 1-in-4 lifetime all-cause dementia incidence; consistent with the Alzheimer's Association 'one in three older Americans dies with Alzheimer's or another dementia' framing
1 in 6.7 · 15%
Population-averaged; women’s higher dementia incidence is partly longevity (they live long enough to reach peak risk ages) and partly plausibly biological
1 in 11 · 9.0%
Lower lifetime figure driven primarily by lower life expectancy; competing mortality removes men from the denominator before peak dementia-risk ages
1 in 13 · 8.0%
Lancet Commission 2024: 45% of dementia cases are theoretically preventable or delayable via 14 modifiable factors; a composite healthy-brain profile yields ~30-50% relative risk reduction in observational cohorts
Bar length and shade rank these scenarios against each other, not against other risks. The exact odds are shown beside each.
Related risks
Other risks on similar themes — for exploring related fears.
Pick challenger
Roughly 57 million people were living with dementia worldwide in 2021 according to the World Health Organization, with nearly 10 million new cases every year and Alzheimer’s disease accounting for 60-70% of them. WHO ranks dementia as the 7th leading cause of death globally; in the US, the Alzheimer’s Association reports it as the 6th leading cause of death among adults 65 and older. Spread across a global adult population and weighted by the fact that dementia incidence is heavily concentrated above age 75, a plausible global lifetime mortality figure is about 1 in 8 — an order of magnitude below cancer but in the same neighbourhood as stroke, and roughly 7,000 times the lifetime odds of dying in a plane crash for a regular flyer. The number rises sharply with life expectancy: in any country where most adults routinely reach 85+, the lifetime dementia risk converges toward 1 in 4. The Alzheimer’s Association’s direct US estimate is that one in three older Americans dies with Alzheimer’s or another dementia.
The interesting thing about dementia in the Likelier catalogue is that it gets cultural attention without getting personal attention. People know Alzheimer’s is “one of the big ones” in the abstract, but the Alzheimer’s Association’s figure that the lifetime risk from age 45 is 1 in 5 for women and 1 in 10 for men is almost never the number readers expect when asked to guess. It is the rare health fear where the gap is not vividness (dementia is, if anything, more vivid than most diseases in fiction and memoir) but numeracy — the cumulative hazard compounds across decades, and the peak-risk ages are the ones most under-65 readers have not yet modelled as “their own”. Likelier tags this underrated on that basis: the headline number is not hidden, but the personal odds attached to it almost always are.
Where the number doesn’t apply: the sex gap on this fear is one of the widest on the site. Women face meaningfully higher lifetime dementia incidence than men — partly because they live long enough to reach the 80+ decade when annual incidence peaks, partly for reasons that are still actively debated in the literature and not fully reducible to longevity alone. The 2024 Lancet Commission on dementia prevention estimates that 45% of dementia cases are theoretically preventable or delayable by addressing 14 modifiable risk factors spanning education, hearing loss, hypertension, physical inactivity, diabetes, smoking, LDL cholesterol, depression, social isolation, air pollution, visual impairment, and a handful of others. That is an unusually high preventable fraction for a major disease. A 60-year-old with 16 years of education, no uncontrolled hypertension, corrected hearing and vision, regular physical activity, and an active social life is not running the headline number; the composite protective profile lowers relative risk by roughly a third in long-term observational cohorts. The opposite end of the distribution — APOE ε4 homozygous carriers — runs roughly an order of magnitude above the population baseline, which is larger than the gap between most pairs of fears in this catalogue.
Related tidbits
Type 2 diabetes and Alzheimer's are both leading causes of death, both strongly linked to lifestyle, and both progress slowly enough that urgency never kicks in. The threats that kill gradually don't trigger the fear response.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] World Health Organization — Dementia — fact sheet
Dementia — fact sheet- Statistic
57 million people worldwide had dementia in 2021, with nearly 10 million new cases every year; dementia is the 7th leading cause of death globally; Alzheimer's disease is the most common form at 60-70% of cases- Excerpt
“"In 2021, 57 million people had dementia worldwide, over 60% of whom live in low-and middle-income countries. Every year, there are nearly 10 million new cases. Alzheimer disease is the most common form of dementia and may contribute to 60–70% of cases. [...] Dementia is currently the seventh leading cause of death and one of the major causes of disability and dependency among older people globally. [...] Women are disproportionately affected by dementia, both directly and indirectly. Women experience higher disability-adjusted life years and mortality due to dementia, but also provide 70% of care hours for people living with dementia." ”
- Source data from
- 2025-03-31
- Accessed
- 2026-04-11 · archived copy
- Calculation
- 57M prevalent cases across ~6.0 billion adults = ~0.95% point prevalence in adults today. 10M annual incident cases across the same adult denominator = ~1.7 per 1,000 adults per year. Naive 60-year compounding gives ~10%; age-weighting for the fact that dementia incidence is heavily concentrated above age 75 (where the annual hazard is several-fold higher than the all-adult average) pulls the realistic lifetime figure toward 12-15% for adults who survive competing mortality. The 7th-leading-cause-of-death framing is the direct mortality anchor. Used as the primary global headline because it is the only source with a concurrent prevalence + incidence + mortality-rank triple that can be reconciled into a single lifetime estimate.
- Independence
- WHO dementia figures draw on the same GBD / IHME upstream as most other institutional citations; treat as partially dependent with any GBD-derived source below.
-
[2] Alzheimer's Association — 2025 Alzheimer's Disease Facts and Figures
2025 Alzheimer's Disease Facts and Figures- Statistic
7.2 million Americans age 65+ living with Alzheimer's in 2025; lifetime risk at age 45 is 1 in 5 for women and 1 in 10 for men; 6th leading cause of death among people 65+; deaths more than doubled 2000-2022- Excerpt
“"An estimated 7.2 million Americans age 65 and older are living with Alzheimer’s in 2025. [...] By 2050, the number of people age 65 and older with Alzheimer’s may grow to a projected 12.7 million. [...] The lifetime risk for Alzheimer’s at age 45 is 1 in 5 for women and 1 in 10 for men. [...] Alzheimer’s disease was the sixth-leading cause of death among people age 65 and older in 2022. [...] One in 3 older Americans dies with Alzheimer’s or another dementia." ”
- Source data from
- 2025-03-05
- Accessed
- 2026-04-11 · archived copy
- Calculation
- ACS-style direct lifetime risk calculation from US life-table conditional on reaching age 45: 20% for women, 10% for men → population-weighted ~15% lifetime Alzheimer’s-specific incidence in the US from mid-life. Adding non-Alzheimer’s dementias (vascular, Lewy body, frontotemporal, mixed) pushes all-cause dementia lifetime incidence from 65 onward to roughly 25% in the US, consistent with the "1 in 3 older Americans dies with Alzheimer’s or another dementia" framing. This is the direct anchor for the US rows in the regional_breakdown below and justifies using ~12% as a global adult floor once LMIC competing mortality is netted out. Note that "lifetime risk at 45" is a conditional-on-reaching-45 figure, not a birth-cohort estimate; the population-averaged figure before conditioning is slightly lower because of pre-45 mortality.
- Independence
- The Alzheimer’s Association synthesizes Chicago Health and Aging Project cohort data, Framingham Heart Study dementia sub-studies, and CDC/NCHS vital registration. Not fully independent from the CDC death-certificate count cited below but uses methodologically distinct cohort-based lifetime-risk estimation.
-
[3] US Centers for Disease Control and Prevention / National Center for Health Statistics — FastStats — Alzheimer Disease
FastStats — Alzheimer Disease- Statistic
116,022 US Alzheimer's deaths (most recent year); 34.1 deaths per 100,000 population; 6th leading cause of death- Excerpt
“"Number of deaths: 116,022. Deaths per 100,000 population: 34.1. Cause of death rank: 6." ”
- Source data from
- 2024-10-25
- Accessed
- 2026-04-11 · archived copy
- Calculation
- 116,022 US Alzheimer’s deaths / ~260 million US adults ≈ 0.45 per 1,000 adults/year. Compounded over 60 adult years naively: 1 − (1 − 4.5e-4)^60 ≈ 0.027, which is the death-certificate floor for Alzheimer’s specifically. The Alzheimer’s Association’s "1 in 3 older Americans dies with dementia" framing is roughly an order of magnitude higher because death certificates typically record the proximal cause (pneumonia, sepsis, cardiac arrest) rather than the underlying dementia. The realistic US lifetime Alzheimer’s-attributable mortality number sits between the CDC floor (~3%) and the "dies with dementia" ceiling (~33%), with most methodologically serious estimates clustering around 10-15% for Alzheimer’s alone and 20-25% for all-cause dementia. Used as the mortality-rank and US-floor anchor.
- Independence
- CDC/NCHS vital registration is the methodological alternative to cohort-based lifetime-risk estimation. Reading this source alongside the Alzheimer’s Association figure gives the floor-vs-ceiling spread that the uncertainty band reflects.
-
[4] Alzheimer's Disease International — Lancet Commission identifies two new risk factors for dementia and suggests 45% of cases could be delayed or reduced
Lancet Commission identifies two new risk factors for dementia and suggests 45% of cases could be delayed or reduced- Statistic
2024 Lancet Commission: 45% of dementia cases could potentially be delayed or reduced by addressing 14 modifiable risk factors- Excerpt
“"45% of cases of dementia could potentially be delayed or reduced, marking a 5% increase from their 2020 findings. [...] failing eyesight and elevated LDL cholesterol levels [were added as new risk factors]. [...] social isolation, air pollution and vision loss [have greater impact] in late life, and less education [has greater impact] in early life." ”
- Source data from
- 2024-07-31
- Accessed
- 2026-04-11 · archived copy
- Calculation
- Used to anchor the personal_factor_multipliers block below. The Lancet Commission’s 45% population-attributable fraction is an upper bound for theoretical modifiable prevention; real-world effect sizes for any individual adult adopting a composite "healthy brain" profile are closer to a 30-50% relative risk reduction vs baseline, which is the 0.6 multiplier used in the regional_breakdown entry for the active/educated/engaged subgroup. The 14 factors span education, hearing loss, high LDL cholesterol, depression, traumatic brain injury, physical inactivity, diabetes, smoking, hypertension, obesity, excessive alcohol, social isolation, air pollution, and visual impairment.
- Independence
- Alzheimer’s Disease International is the global federation of national Alzheimer’s associations; this page is a summary of the peer-reviewed Lancet Commission 2024 report (Livingston et al., The Lancet, 2024). The underlying Commission is independent from the WHO / CDC mortality pipelines above.
-
[5] Livingston et al., The Lancet (Vol 404, Aug 10, 2024) — Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Dementia prevention, intervention, and care: 2024 report of the Lancet standing CommissionSee all 2 Likelier entries citing this source →
- Statistic
Hearing loss: RR for dementia 1.4 (95% CI 1.0-1.9), weighted PAF 7% — the joint-highest of the Commission's 14 modifiable factors; dose-response 4-24% per 10 dB; hearing-aid use HR 0.83 (0.77-0.90) for dementia- Excerpt
“"We did new meta-analyses for only depression and hearing loss (as there were no recent reviews) [...] The magnitude of this risk increase varied between studies, from a 4% increase to a 24% increase in dementia risk per 10 dB decrease in hearing ability. [...] a systematic review and meta-analysis of eight cohort studies with 126903 participants [...] reported that people with hearing loss who used hearing aids had a significantly lower risk of [...] dementia (0·83, 0·77–0·90 [...])." Table 1 (RR for dementia, 95% CI): Hearing loss 1·4 (1·0–1·9); weighted PAF 7% (rounded), the joint-largest modifiable fraction alongside high LDL cholesterol. ”
- Source data from
- 2024-07-31
- Accessed
- 2026-06-14
- Calculation
- The Commission's Table 1 reports a relative risk of 1.4 (95% CI 1.0-1.9) for dementia in adults with mid-life hearing loss, from a new meta-analysis run for this report. This RR is used verbatim as the 1.4 multiplier in personal_factor_multipliers (rounded as-published). Hearing loss carries the joint-highest weighted PAF (7%) of the 14 factors, hence the "single largest modifiable risk factor" framing — though it is tied with high LDL cholesterol at 7%, so the entry phrases it as joint-highest, not sole. The hearing-aid figure (HR 0.83) is observational, not from an RCT primary endpoint (the ACHIEVE RCT found no overall effect but a substantial effect in its higher-risk ARIC subgroup), so it is recorded as "associated with lower risk", not as a proven protective multiplier.
- Independence
- This is the underlying peer-reviewed Commission report summarised by the Alzheimer's Disease International page cited above; the two are not independent. It is independent of the WHO / CDC mortality pipelines. Added specifically to give the hearing-loss multiplier a clean primary provenance.